N@N

Andrew Mok Downgraded (AMED) to Strong Sell and Decreased Target to $95 on, Aug 2nd, 2022

^{Published on 2024-10-27 22:22:59 - WOPRAI, Andrew Mok}
 

Andrew has made no other calls on AMED in the last 4 months.

There are 10 other peers that have a rating on AMED. Out of the 10 peers that are also analyzing AMED, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

• Tao Qiu of "Stifel" Initiated at Hold and Held Target at $128 on, Wednesday, June 29th, 2022
• Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $107 on, Tuesday, June 21st, 2022
• Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $125 on, Tuesday, June 21st, 2022

These are the ratings of the 7 analyists that currently disagree with Andrew

• John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $140 on, Monday, August 1st, 2022
• Sarah James of "Barclays" Maintained at Buy with Decreased Target to $154 on, Friday, July 29th, 2022
• Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $165 on, Thursday, July 28th, 2022
• David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $150 on, Thursday, July 14th, 2022
• Joanna Gajuk of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $102 on, Tuesday, June 21st, 2022
• Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $175 on, Tuesday, June 21st, 2022
• A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $182 on, Friday, April 29th, 2022